Table 3 Bivariate analysis of patient factors related to the hypertensive phase.
From: Effect of intracameral air injection during Ahmed glaucoma valve implantation on hypertensive phase
No HP (n = 46) | HP (n = 32) | P value | |
|---|---|---|---|
Age (years) | 61.8 ± 12.5 | 54.6 ± 11.9 | 0.012~ |
Sex (M/F) | 30 (65.2%) /16 (34.8%) | 18(56.3%)/14(43.8%) | 0.423* |
Diabetes (Yes/No) | 36 (78.3%)/10 (21.7%) | 19(59.4%)/13(40.6%) | 0.072* |
Phakic/Pseudophakic | 12 (26.1%) /34 (73.9%) | 5(15.6%) /27 (84.4%) | 0.271* |
NVG (Yes/No) | 25 (54.3%) /21 (45.7%) | 13(40.6%)/19(59.4%) | 0.233* |
Axial length (mm) | 23.99 ± 1.31 | 24.60 ± 2.09 | 0.169~ |
Air injection (Yes/No) | |||
Yes | 17 (80.9%) | 4 (19.0%) | 0.017* |
No | 29 (50.9%) | 28 (49.1%) | |
Prior glaucoma surgery (Yes/No) | 9 (19.6%) /37 (80.4%) | 12(37.5%)/20(62.5%) | 0.079* |
Baseline IOP (mmHg) | 31.3 ± 7.9 | 33.4 ± 7.6 | 0.241~ |
